CANbridge Pharmaceuticals Inc.

HKEX:1228.HK

0.195 (HKD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q3
Assets:
Current Assets:
Cash & Cash Equivalents 49.09849.098124.901137.491271.16283.558451.157463.107604.616604.616745.815745.815442.1408.601360.804360.804
Short Term Investments 0000000000000000
Cash and Short Term Investments 49.09849.098124.901137.491271.16283.558451.157463.107604.616604.616745.815745.815442.1408.601360.804360.804
Net Receivables 28.46428.46431.22831.22826.38726.38719.05419.05414.55314.5539.1419.1417.1286.0877.047.04
Inventory 12.67312.6738.7838.78319.88319.8839.8249.8249.6029.60213.44813.4481.2691.7930.5530.553
Other Current Assets 11.97311.97332.36232.36212.42512.42513.17513.17525.34825.34843.30743.30729.93510.7122.64822.648
Total Current Assets 102.208102.208209.864209.864342.253342.253505.16505.16654.119654.119811.711811.711480.432427.191391.045391.045
Non-Current Assets:
Property, Plant & Equipment, Net 75.12375.123109.007109.007141.679141.679125.595144.717131.339131.33929.54229.54216.08915.54115.5715.57
Goodwill 0000000000000000
Intangible Assets 71.61671.61676.49176.49183.38583.38568.13349.01150.18550.18551.26951.26954.8556.78179.743179.743
Goodwill and Intangible Assets 71.61671.61676.49176.49183.38583.38568.13349.01150.18550.18551.26951.26954.8556.78179.743179.743
Long Term Investments 0000000000000000
Tax Assets 0000000000000000
Other Non-Current Assets 00001.731.733.1573.1576.8076.807000000
Total Non-Current Assets 146.739146.739185.498185.498226.794226.794196.885196.885188.331188.33180.81180.81170.93972.321195.313195.313
Total Assets 248.947248.947395.362395.362569.047569.047702.045702.045842.45842.45892.522892.522551.371499.512586.358586.358
Liabilities & Equity:
Current Liabilities:
Account Payables 307.237307.237198.054198.054172.234172.234107.54107.54108.307108.30743.60743.60742.10860.01346.71346.713
Short Term Debt 41.541.534.72434.72436.68436.68439.89539.89535.46535.46538.7538.7519.77919.24727.83327.833
Tax Payables 002.4770001.3820001.47701.11500.9950
Deferred Revenue 011.193-11.0340000000000000
Other Current Liabilities 68.45168.45192.6995.167121.557121.557129.288130.6770.87370.873101.946103.42337.92338.89532.56233.557
Total Current Liabilities 417.188417.188327.945327.945330.475330.475278.105278.105214.645214.645185.78185.78100.925118.155108.103108.103
Non-Current Liabilities:
Long Term Debt 111.997111.997107.205107.205115.131115.131115.385115.38512112113.35113.35110.1672,221.82719.0622,186.183
Deferred Revenue Non-Current 0000000000000000
Deferred Tax Liabilities Non-Current 0000000000000000
Other Non-Current Liabilities 0000000000002,505.07729.7682,205.04937.928
Total Non-Current Liabilities 111.997111.997107.205107.205115.131115.131115.385115.38512112113.35113.3512,515.2442,251.5952,224.1112,224.111
Total Liabilities 529.185529.185435.15435.15445.606445.606393.49393.49335.645335.645199.131199.1312,616.1692,369.752,332.2142,332.214
Equity:
Preferred Stock 03,491.6213,789.44200000002,777.24402,074.38401,772.2250
Common Stock 0.0280.0280.0280.0280.0280.0280.0280.0280.0280.0280.0280.0280.0050.0050.0050.005
Retained Earnings -4,036.711-4,036.711-3,789.442-3,789.442-3,628.766-3,628.766-3,410.605-3,410.605-3,176.142-3,176.142-2,927.13-2,927.13-2,194.327-1,962.487-1,850.124-1,850.124
Accumulated Other Comprehensive Income/Loss 264.824264.824-39.816276.549278.96278.96247.876247.876212.312212.312149.886149.886119.94382.66377.89977.899
Other Total Stockholders Equity 3,491.6213,491.6213,749.6263,473.0773,473.2193,473.2193,471.2563,471.2563,470.6073,470.607693.3633,470.607-4,259.139.58126.36426.364
Total Shareholders Equity -280.238-280.238-39.788-39.788123.441123.441308.555308.555506.805506.805693.391693.391-2,064.798-1,870.238-1,745.856-1,745.856
Total Equity -280.238-280.238-39.788-39.788123.441123.441308.555308.555506.805506.805693.391693.391-2,064.798-1,870.238-1,745.856-1,745.856
Total Liabilities & Shareholders Equity 248.947248.947395.362395.362569.047569.047702.045702.045842.45842.45892.522892.522551.371499.512586.358586.358